UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Medline ® Abstract for Reference 55

of 'Systemic therapy for advanced non-small cell lung cancer with an activating mutation in the epidermal growth factor receptor'

55
 
 
Riely GJ, et al. Response to erlotinib and prognosis for patients with de novo epidermal growth factor receptor T790M mutations (abstract 8018). American Society of Clinical Oncology 2013 meeting.
 
no abstract available